Literature DB >> 26639948

Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision.

Lisa Szatkowski1, Paul Aveyard2.   

Abstract

BACKGROUND: Before 2012, UK GPs were paid only to offer cessation advice to smokers and only to those with smoking-related disease, a minority of all smokers. From 2012, GPs are now paid to offer all smokers referral for behavioural support and medication to assist cessation at least once every 2 years. AIM: To quantify the impact of this new recommendation and payment on indicators of smoking cessation activity. DESIGN AND
SETTING: Interrupted time series analysis of data from general practices in England contributing data to The Health Improvement Network (THIN).
METHOD: Data were extracted on monthly rates of recorded delivery of smoking cessation advice, referral to NHS Stop Smoking Services, and prescription of smoking cessation medications, among an average of 3.3 million patients aged >16 years registered each month in THIN. ARIMA models were used to quantify changes in rates of cessation activity after the 2012 Quality and Outcomes Framework (QOF) revision compared with beforehand.
RESULTS: The proportion of patients each month with a record of advice to quit smoking increased by 19.6% (95% CI = 7.9 to 31.4) in the year after the introduction of payments compared with the 8 years beforehand; the recording of referral to Stop Smoking Services increased by 38.8% (95% CI = 15.2 to 62.4). There was no significant change in prescription of smoking cessation medication, -7.7% (95% CI = -21.6 to 6.2).
CONCLUSION: Paying GPs to intervene with all smokers and offer support rather than just advice to quit is associated with an increase in recording of advice and referring patients for behavioural support to stop smoking, but no change in prescribing pharmacotherapy for cessation. © British Journal of General Practice 2016.

Entities:  

Keywords:  financial incentive; interrupted time series analysis; prescribing patterns; primary care; smoking cessation; tobacco use

Mesh:

Year:  2015        PMID: 26639948      PMCID: PMC4684030          DOI: 10.3399/bjgp15X688117

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

1.  Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.

Authors:  Tessa E Langley; Lisa Szatkowski; Jack Gibson; Yue Huang; Ann McNeill; Tim Coleman; Sarah Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

2.  Impact of contractual financial incentives on the ascertainment and management of smoking in primary care.

Authors:  Tim Coleman; Sarah Lewis; Richard Hubbard; Christopher Smith
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

Review 3.  The effectiveness of NHS smoking cessation services: a systematic review.

Authors:  Linda Bauld; Kirsten Bell; Lucy McCullough; Lindsay Richardson; Lorraine Greaves
Journal:  J Public Health (Oxf)       Date:  2009-07-28       Impact factor: 2.341

4.  A comparison of patient recall of smoking cessation advice with advice recorded in electronic medical records.

Authors:  Lisa Szatkowski; Ann McNeill; Sarah Lewis; Tim Coleman
Journal:  BMC Public Health       Date:  2011-05-10       Impact factor: 3.295

5.  The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.

Authors:  Lisa Szatkowski; Tim Coleman; Ann McNeill; Sarah Lewis
Journal:  Addiction       Date:  2011-07-27       Impact factor: 6.526

Review 6.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 7.  Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance.

Authors:  Paul Aveyard; Rachna Begh; Amanda Parsons; Robert West
Journal:  Addiction       Date:  2012-02-28       Impact factor: 6.526

8.  Can primary care data be used to monitor regional smoking prevalence? An analysis of The Health Improvement Network primary care data.

Authors:  Tessa E Langley; Lisa C Szatkowski; Stephen Wythe; Sarah A Lewis
Journal:  BMC Public Health       Date:  2011-10-07       Impact factor: 3.295

9.  The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database.

Authors:  Jaspal S Taggar; Tim Coleman; Sarah Lewis; Lisa Szatkowski
Journal:  BMC Public Health       Date:  2012-07-10       Impact factor: 3.295

10.  Can data from primary care medical records be used to monitor national smoking prevalence?

Authors:  Lisa Szatkowski; Sarah Lewis; Ann McNeill; Yue Huang; Tim Coleman
Journal:  J Epidemiol Community Health       Date:  2011-05-13       Impact factor: 3.710

View more
  12 in total

1.  Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study).

Authors:  Sabrina Kastaun; Daniel Kotz; Jamie Brown; Lion Shahab; Melanie Boeckmann
Journal:  BMJ Open       Date:  2019-08-27       Impact factor: 2.692

2.  Examining the effectiveness of general practitioner and nurse promotion of electronic cigarettes versus standard care for smoking reduction and abstinence in hardcore smokers with smoking-related chronic disease: protocol for a randomised controlled trial.

Authors:  Rachna Begh; Tim Coleman; Lucy Yardley; Rebecca Barnes; Felix Naughton; Hazel Gilbert; Anne Ferrey; Claire Madigan; Nicola Williams; Louisa Hamilton; Yolanda Warren; Jenna Grabey; Miranda Clark; Anne Dickinson; Paul Aveyard
Journal:  Trials       Date:  2019-11-28       Impact factor: 2.279

3.  Time trends in access to smoking cessation support for people with depression or severe mental illness: a cohort study in English primary care.

Authors:  Milena Falcaro; David Osborn; Joseph Hayes; Gary Coyle; Lisa Couperthwaite; Scott Weich; Kate R Walters
Journal:  BMJ Open       Date:  2021-12-03       Impact factor: 2.692

Review 4.  An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement.

Authors:  Jill M Williams; Marc L Steinberg; Alexandra N Kenefake; Michael V Burke
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

5.  A gateway to more productive research on e-cigarettes? Commentary on a comprehensive framework for evaluating public health impact.

Authors:  Jamie Brown
Journal:  Addiction       Date:  2016-07-22       Impact factor: 6.526

6.  Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?

Authors:  Athif Ilyas; Edward Chesney; Rashmi Patel
Journal:  Br J Psychiatry       Date:  2017-09-07       Impact factor: 9.319

7.  OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998-2016.

Authors:  Helen J Curtis; Ben Goldacre
Journal:  BMJ Open       Date:  2018-02-23       Impact factor: 2.692

8.  An observational study of system-level changes to improve the recording of very brief advice for smoking cessation in an inpatient mental health setting.

Authors:  Gilda Spaducci; Sol Richardson; Ann McNeill; Megan Pritchard; Jyoti Sanyal; Andy Healey; Mary Yates; Debbie Robson
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

9.  Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review.

Authors:  Celestin Hategeka; Hinda Ruton; Mohammad Karamouzian; Larry D Lynd; Michael R Law
Journal:  BMJ Glob Health       Date:  2020-10

10.  The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study.

Authors:  Edward Chesney; Deborah Robson; Rashmi Patel; Hitesh Shetty; Sol Richardson; Chin-Kuo Chang; Philip McGuire; Ann McNeill
Journal:  Schizophr Res       Date:  2021-09-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.